DGX
Quest Diagnostics Incorporated
236.30$
-0.1%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -0.3% | +3.4% | +1.3% | +3.8% | +5.3% | +1.2% | +4.1% | +2.0% | -0.4% | +3.2% | +5.1% | – | |
| – | +0.5% | +3.0% | -0.1% | +5.3% | +5.1% | +1.5% | +1.6% | +2.7% | +1.3% | +3.2% | +3.2% | – | |
| – | -1.9% | +4.2% | +4.3% | +0.9% | +5.8% | +0.6% | +9.3% | +0.6% | -3.7% | +3.1% | +9.0% | – | |
| – | +8.2% | +8.1% | -5.5% | +7.7% | +4.0% | +2.1% | +2.1% | +3.1% | -3.0% | +3.7% | +5.0% | – | |
| – | +14.8% | -0.4% | -4.7% | +7.1% | +3.3% | +4.0% | -2.3% | +11.5% | -7.1% | +3.8% | +4.6% | – | |
| – | -21.9% | +12.4% | +18.3% | -7.0% | +9.4% | -4.2% | +26.6% | -11.9% | +1.3% | +2.0% | +15.0% | – | |
| – | +12.2% | +6.5% | -4.1% | +23.4% | +24.1% | +0.0% | -4.2% | +0.0% | -2.9% | -6.0% | +0.0% | – | |
| – | -19.7% | +11.8% | +14.6% | -3.8% | +0.7% | -3.3% | +33.7% | -14.5% | +0.3% | -0.9% | +23.4% | – | |
| – | -41.2% | +65.0% | +12.1% | -12.2% | +4.6% | -13.2% | +64.4% | -20.6% | +5.2% | -8.6% | +18.9% | – | |
| – | -14.7% | +1.0% | +18.0% | -1.3% | -1.8% | -0.9% | +28.2% | -13.1% | +0.0% | +2.9% | +27.0% | – | |
| – | -13.1% | +9.9% | +10.9% | +0.2% | +5.8% | -3.7% | +22.1% | -8.2% | -0.2% | -20.5% | +10.8% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.